Equine Cushings And Insulin Resistance Group Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2013 | 35,141 | 20,190 | 14,951 | 10.0 | 0% |
| 2015 | 65,985 | 35,471 | 30,514 | 20.9 | — |
| 2017 | 95,205 | 52,222 | 42,983 | 25.4 | — |
| 2020 | 54,720 | 17,190 | 37,530 | 112.3 | — |
| 2021 | 175,615 | 37,061 | 138,554 | 96.9 | — |
| 2022 | 48,760 | 29,350 | 19,410 | 130.3 | — |
| 2023 | 70,732 | 11,806 | 58,926 | 383.9 | — |
In its most recent public year (2023), this organization brought in $58,926 more than it spent. Its reserves stood at about 383.9 months of spending, up from 10 in 2013.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Equine Cushings And Insulin Resistance Group Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works